12 Health Care Stocks Moving In Tuesday's After-Market Session
Portfolio Pulse from Benzinga Insights
Several healthcare stocks experienced significant movement in Tuesday's after-market session. Galecto, Exagen, MSP Recovery, Brainstorm Cell, VYNE Therapeutics, and Freeline Therapeutics saw increases, while Minerva Surgical, Femasys, DMK Pharmaceuticals, Adial Pharmaceuticals, Tharimmune, and SeqLL experienced decreases.
September 26, 2023 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Adial Pharmaceuticals' shares declined by 11.58% to $2.75.
The decline in Adial Pharmaceuticals' stock price indicates negative market sentiment, which could result in a short-term downward trend.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
DMK Pharmaceuticals' stock decreased by 15.25% to $0.65.
The decrease in DMK Pharmaceuticals' stock price suggests negative market sentiment, potentially leading to a short-term downward trend.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Femasys' stock fell 16.22% to $1.24.
The fall in Femasys' stock price indicates negative market sentiment, which could result in a short-term downward trend.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
SeqLL's shares decreased by 10.41% to $16.53.
The decrease in SeqLL's stock price indicates negative market sentiment, which could result in a short-term downward trend.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Tharimmune's shares declined by 11.19% to $0.26.
The decline in Tharimmune's stock price suggests negative market sentiment, potentially leading to a short-term downward trend.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Minerva Surgical's shares decreased by 23.5% to $0.22.
The significant decrease in Minerva Surgical's stock price is likely due to negative market sentiment. This could lead to a short-term downward trend in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Brainstorm Cell's stock rose 10.96% to $0.43.
The rise in Brainstorm Cell's stock price indicates positive market sentiment, which could result in a short-term upward trend.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Freeline Therapeutics' stock increased by 9.24% to $4.16.
The increase in Freeline Therapeutics' stock price indicates positive market sentiment, which could result in a short-term upward trend.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Galecto's stock increased by 40.3% to $0.81 during Tuesday's after-market session.
The significant increase in Galecto's stock price is likely due to positive market sentiment. This could lead to a short-term upward trend in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
MSP Recovery's stock moved upwards by 13.87% to $0.17.
The upward movement in MSP Recovery's stock price suggests positive market sentiment, potentially leading to a short-term upward trend.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
VYNE Therapeutics' stock increased by 9.62% to $3.76.
The increase in VYNE Therapeutics' stock price suggests positive market sentiment, potentially leading to a short-term upward trend.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Exagen's stock increased by 15.76% to $2.79.
The increase in Exagen's stock price indicates positive market sentiment, which could result in a short-term upward trend.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100